Envision Pharma Group appoints new CEO

Published on: 

Envision Pharma Group is pleased to announce the appointment of Meg Heim as its new Chief Executive Officer. Throughout her career she has championed the professionalism of medical affairs and the innovations that improve patient experience.

Working closely with an experienced Executive Leadership Team, Meg will be responsible for delivering an ambitious five-year plan that will reinforce Envision a the global leader in scientific and commercialization strategy and solutions, medical affairs, and lifecycle planning.


Meg said: “I am energized to be joining Envision Pharma Group at such an important time in the industry. I see a clear opportunity for further growth building off established and new opportunities in the sector. The company has an exceptional team and client base, and I am looking forward to spending time with our people, our clients, and other key partners.”